@KorecyteBio

We are developing in vivo CAR-T therapies that target and reprogramme solid tumours in a single, scalable approach

Joined January 2023
  • Tweets3
  • Following3
  • Followers15
2Media
Korecyte Bio is excited to announce that we have incorporated in the UK! Korecyte Innovations Ltd will pioneer our R&D activities for next generation hypoxia-sensing #CART approaches for treating #cancer
6
145
Exciting to see our first 20 new hypoxia-sensing CAR-T constructs in viruses ready for testing. Korecyte’s R&D is underway on our mission for developing less toxic and more efficacious #CART treatments for solid #cancers
4
141
An exciting day for Korecyte Bio! We have finalised a commercial contract with @KingsCollegeLon to pursue hypoxia-sensing #CART #Immunotherapy. A technology for treating solid cancers while avoiding off-tumour activation to lower toxicities for CAR-T. kcl.ac.uk/news/kings-signs-c…

King's signs commercial contract with cellular immunotherapy startup Korecyte Bio | King's College...

Korecyte Bio is leading a new approach to CAR T-cell immunotherapy to focus killing potential on cancer cells and reduce toxic side effects to help fight solid tumours.

kcl.ac.uk
1
137
Load more